Related Experiment Video
Updated: Jul 5, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Statistical issues in the evaluation of screening and early detection modalities
1Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. retztioni@fhcrc.org
Evaluating screening tests like prostate-specific antigen (PSA) for cancer involves assessing diagnostic accuracy and benefits. This review details methods for evaluating screening effectiveness and discusses challenges, particularly with limited trial data.
Area of Science:
- Medical screening test evaluation
- Prostate cancer diagnostics
- Public health policy
Background:
- Comprehensive evaluation of screening tests is crucial for accurate disease detection, benefit assessment, and cost-effectiveness.
- Prostate-specific antigen (PSA) screening for prostate cancer serves as a key case study for evaluating screening methodologies.
Purpose of the Study:
- To review the methodologies for evaluating screening tests, using PSA screening for prostate cancer as a model.
- To discuss the quantification of diagnostic properties and the comparison of varying diagnostic accuracy estimates.
- To explore methods for enhancing test accuracy and assessing screening benefits, especially when randomized trial data is scarce.
Main Methods:
- Review of study designs for quantifying diagnostic properties of screening tests.
- Comparison of diverse studies yielding different estimates of PSA screening accuracy.
- Examination of methods to combine markers with PSA for improved accuracy.
- Analysis of observational studies and computer models to infer screening benefits from population mortality trends.
Main Results:
- Different study designs produce varying estimates of PSA screening's diagnostic accuracy.
- Combining PSA with other markers or tests can potentially improve diagnostic performance.
- Inferring screening benefits is complex, often relying on observational data and modeling when randomized trials are absent.
Conclusions:
- Rigorous evaluation encompassing diagnostic accuracy, benefits, and costs is essential for any screening test.
- Methodological choices significantly impact the estimated accuracy and perceived benefits of screening tests like PSA.
- Further research and advanced modeling are needed to fully understand the population-level impact of screening interventions.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Statistical Methods for Analyzing Epidemiological Data
Cancer Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...